Valganciclovir is a medication used to treat infections caused by a virus called cytomegalovirus (CMV). It is commonly prescribed for people with weakened immune systems, such as those who have had an organ transplant, to prevent or treat CMV infections. Valganciclovir helps to stop the virus from spreading and causing problems in the body.
Cytomegalovirus Retinitis, Induction And Maintenance Treatment In Patients With Aids:
Adult: Initially 900 Mg Twice Daily For 21 Days, Then 900 Mg Daily, Induction Regimen May Be Repeated If Retinitis Progresses
Prevention Of Cytomegalovirus Disease Following Solid Organ Transplantation From A Cytomegalovirus Positive Donor:
Adult: 900 Mg Daily For 100 Days (for 100-200 Days Following Kidney Transplantation), To Be Started Within10 Days Of Transplantation
Content
Tab: Valganciclovir (as Hydrochloride) 450mg.
Pregnancy
Avoid; Teratogenic Risk
Stability
Dna Polymerase Inhibitor Prodrug,
Contra Indications
Hypersensitivity To Ganciclovir Or Acyclovir, Abnormally Low Haemoglobin, Neutrophil, Or Platelet Counts.
Precautions
Hypersensitivity To Ganciclovir Or Acyclovir, Abnormally Low Haemoglobin, Neutrophil, Or Platelet Counts.